Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Jones

Showing results (241-250 of 281) with videos related to

Pageof 29
Sort By:
Breast Cancer Research and Treatment|April 15, 2008
Src inhibitors in early breast cancer: a methodology, feasibility and variability studyR J Jones, O Young, L Renshaw, et al.
Blood|August 1, 1995
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsA Bedi, J P Barber, G C Bedi, et al.
Blood|July 1, 1989
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemiaS D Rowley, R J Jones, S Piantadosi, et al.
Cancer Research|May 1, 1995
Inhibition of apoptosis during development of colorectal cancerA Bedi, P J Pasricha, A J Akhtar, et al.
British Journal of Haematology|September 12, 1998
Inhibited apoptosis and drug resistance in acute myeloid leukaemiaB D Smith, B J Bambach, M S Vala, et al.
Blood|July 1, 1987
CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrowS D Rowley, M Zuehlsdorf, H G Braine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Quality in Health Care : QHC|June 10, 2000
What type of filling? Best practice in dental restorationsB L Chadwick, P M Dummer, F D Dunstan, et al.
British Journal of Cancer|July 21, 2012
Expression and prognostic significance of Src family members in renal clear cell carcinomaT Qayyum, P A McArdle, G W Lamb, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Pageof 29

Showing results (241-250 of 281) with videos related to

Sort By:
Pageof 29
Breast Cancer Research and Treatment|April 15, 2008
Src inhibitors in early breast cancer: a methodology, feasibility and variability studyR J Jones, O Young, L Renshaw, et al.
Blood|August 1, 1995
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsA Bedi, J P Barber, G C Bedi, et al.
Blood|July 1, 1989
Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemiaS D Rowley, R J Jones, S Piantadosi, et al.
Cancer Research|May 1, 1995
Inhibition of apoptosis during development of colorectal cancerA Bedi, P J Pasricha, A J Akhtar, et al.
British Journal of Haematology|September 12, 1998
Inhibited apoptosis and drug resistance in acute myeloid leukaemiaB D Smith, B J Bambach, M S Vala, et al.
Blood|July 1, 1987
CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrowS D Rowley, M Zuehlsdorf, H G Braine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemiaE K Rowinsky, A Adjei, R C Donehower, et al.
Quality in Health Care : QHC|June 10, 2000
What type of filling? Best practice in dental restorationsB L Chadwick, P M Dummer, F D Dunstan, et al.
British Journal of Cancer|July 21, 2012
Expression and prognostic significance of Src family members in renal clear cell carcinomaT Qayyum, P A McArdle, G W Lamb, et al.
Bone Marrow Transplantation|August 28, 1998
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactionsE J Fuchs, A Seber, V Altomonte, et al.
Pageof 29